1. Home
  2. CERS vs FSBW Comparison

CERS vs FSBW Comparison

Compare CERS & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • FSBW
  • Stock Information
  • Founded
  • CERS 1991
  • FSBW 1936
  • Country
  • CERS United States
  • FSBW United States
  • Employees
  • CERS N/A
  • FSBW N/A
  • Industry
  • CERS EDP Services
  • FSBW Banks
  • Sector
  • CERS Technology
  • FSBW Finance
  • Exchange
  • CERS Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • CERS 347.3M
  • FSBW 299.5M
  • IPO Year
  • CERS 1997
  • FSBW 2012
  • Fundamental
  • Price
  • CERS $1.27
  • FSBW $38.41
  • Analyst Decision
  • CERS Strong Buy
  • FSBW Hold
  • Analyst Count
  • CERS 2
  • FSBW 1
  • Target Price
  • CERS $3.50
  • FSBW $44.00
  • AVG Volume (30 Days)
  • CERS 1.2M
  • FSBW 17.5K
  • Earning Date
  • CERS 05-01-2025
  • FSBW 07-22-2025
  • Dividend Yield
  • CERS N/A
  • FSBW 2.89%
  • EPS Growth
  • CERS N/A
  • FSBW N/A
  • EPS
  • CERS N/A
  • FSBW 4.31
  • Revenue
  • CERS $185,144,000.00
  • FSBW $139,608,000.00
  • Revenue This Year
  • CERS $22.37
  • FSBW $8.34
  • Revenue Next Year
  • CERS $8.46
  • FSBW $5.99
  • P/E Ratio
  • CERS N/A
  • FSBW $8.91
  • Revenue Growth
  • CERS 13.06
  • FSBW 0.22
  • 52 Week Low
  • CERS $1.12
  • FSBW $31.46
  • 52 Week High
  • CERS $2.54
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • CERS 46.48
  • FSBW 44.21
  • Support Level
  • CERS $1.21
  • FSBW $37.50
  • Resistance Level
  • CERS $1.35
  • FSBW $39.27
  • Average True Range (ATR)
  • CERS 0.06
  • FSBW 0.87
  • MACD
  • CERS -0.00
  • FSBW -0.25
  • Stochastic Oscillator
  • CERS 38.89
  • FSBW 23.33

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: